The present application discloses antibodies or antigen binding fragment thereof specifically recognizing and binding an extracellular polypeptide region of human NBCn1. Experimental data are detailed for mouse NBCn1 antibodies. The medical use of such antibodies is claimed, in particular for the treatment of hyperproliferative disorders, such as cancer, or atherosclerosis and/or restenosis.
